Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

27 Aug 2019

Abstract excerpt

Importance: Induction chemotherapy followed by high-dose therapy with autologous stem cell transplant and subsequent antidisialoganglioside antibody immunotherapy is standard of care for patients with high-risk neuroblastoma, but survival rate among these patients remains low. Objective: To determine if tandem autologous transplant improves event-free survival (EFS) compared with single transplant. Design,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31454045
DOI: 10.1001/jama.2019.11642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk NeuroblastomaPMID 31454045Read ↗

Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab betaSemantic proximity Read ↗

Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 studySemantic proximity Read ↗

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II StudySemantic proximity Read ↗

Children’s Oncology Group’s 2023 Blueprint for Research: Cellular Therapy and Stem Cell TransplantationSemantic proximity Read ↗

Risk of Developing Second Malignant Neoplasms in Patients with Neuroblastoma: A Population Study of the US SEER DatabaseSemantic proximity Read ↗

Survival of high‐risk pediatric neuroblastoma patients in a developing countrySemantic proximity Read ↗

60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer ImmunotherapySemantic proximity Read ↗

Human cancer-targeted immunity via transgenic hematopoietic stem cell progenySemantic proximity Read ↗

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patientsSemantic proximity Read ↗

Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort StudySemantic proximity Read ↗

Mesenchymal Transition as a Potential Mechanism of Late Immune Evasion in Neuroblastoma: A Case of Late Relapse after Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCTSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.